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Background: Several human cancers are known to be associated with inflammation and/or viral infections.
However, the influence of tumour-related inflammation on viral uptake is largely unknown. In this study we used
oesophageal squamous cell carcinoma (OSCC) as a model system since this type of cancer is associated with
chronic irritation, inflammation and viral infections. Although still debated, the most important viral infection seems
to be with Human Papillomavirus (HPV). The present study focused on a possible correlation between
inflammation, OSCC development and the influence of HPV infection.
Methods: A total of 114 OSCC biopsies and corresponding normal tissue were collected at Groote Schuur Hospital
and Tygerberg Hospital, Cape Town (South Africa), that were subjected to RNA and DNA isolation. RNA samples
were analysed by quantitative Light Cycler RT-PCR for the expression of selected genes involved in inflammation
and infection, while conventional PCR was performed on the DNA samples to assess the presence of integrated
viral DNA. Further, an in vitro infection assay using HPV pseudovirions was established to study the influence of
inflammation on viral infectivity using selected cell lines.
Results: HPV DNA was found in about 9% of OSCC patients, comprising predominantly the oncogenic type
HPV18. The inflammatory markers IL6 and IL8 as well as the potential HPV receptor ITGA6 were significantly
elevated while IL12A was downregulated in the tumour tissues. However, none of these genes were expressed in
a virus-dependent manner. When inflammation was mimicked with various inflammatory stimulants such as
benzo-α-pyrene, lipopolysaccharide and peptidoglycan in oesophageal epithelial cell lines in vitro, HPV18
pseudovirion uptake was enhanced only in the benzo-α-pyrene treated cells. Interestingly, HPV pseudovirion
infectivity was independent of the presence of the ITGA6 receptor on the surface of the tested cells.
Conclusion: This study showed that although the carcinogen benzo-α-pyrene facilitated HPV pseudovirion uptake
into cells in culture, HPV infectivity was independent of inflammation and seems to play only a minor role in
oesophageal cancer.
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Viral infections are known to contribute to the develop-
ment of several human cancers, the best known being the
association of Human Papillomavirus (HPV) with cervical
cancer [1]. Tumorigenesis can be induced by infectious
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reproduction in any medium, provided the orcellular transformation by oncogene insertion, inhibition of
tumour suppressors and induction of immunosuppression
[2]. While the consequences of inflammation on tumour
initiation and progression are well studied [3,4], the rela-
tionship between inflammation and viral infections in car-
cinogenesis is much less understood.
The incidence of oesophageal cancer is highly variable
depending on geographical and ethnic parameters. High
risk areas include the so-called Asian oesophageal cancer
belt from eastern Turkey, through Iraq, Iran and into
Western and Northern China as well as Eastern-SouthernLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Oesophageal cancer is the most common cancer among
black South African men, and is second to cervical carcin-
oma in black women [6]. There are two major types of
oesophageal cancer: squamous cell carcinoma (OSCC) and
adenocarcinoma, the former being the predominant form
in developing countries. While chronic, frequent reflux of
gastric acid into the distal oesophagus is considered as
the primary factor underlying most cases of oesophageal
adenocarcinoma affecting predominantly white popula-
tions [7], oesophageal squamous-cell carcinomas are more
frequent among Black and Asian populations and are most
strongly associated with smoking, alcohol intake, lack of
fresh fruit and vegetables in the diet, and infections [8,9].
Although still debated due to conflicting results, infection
with HPV that was shown to be correlated to nasopharyn-
geal cancer [10] is thought to be an aetiological factor in
OSCC depending on the geographical region with preva-
lence ranging from 0% to 71% [10-16]. This is in contrast
to other types of cancer that are clearly related to HPV in-
fection such as cervical cancers [1]. It is assumed that only
oesophageal cancers originating from high-incidence geo-
graphic areas are associated with HPV infection, particu-
larly with the high-risk types 16 and 18 [11,17-20].
Previous studies from our laboratory revealed a correl-
ation between HPV infection and oesophageal cancer in
patients from the Transkei (Eastern Cape), a particularly
high-risk area in South Africa: 46% were infected with
HPV with the predominant type being HPV11 [14,21].
In the present study we investigated the role of HPV in-
fection of OSCC patients from the Western Cape (South
Africa) and specifically focussed on a possible correl-
ation between inflammation and OSCC, the influence of
HPV infection for tumour-associated inflammation, and
the role of inflammation for virus uptake. To our know-
ledge, there is little information on the potential role of
chronic inflammation in the aetiology of HPV-associated
OSCC, with a possible connection being described for
a subset of head and neck squamous cell carcinoma
(HNSCC) [22].
The genes that were selected in the present study for
analysis of altered gene expression in the tumour sam-
ples were p16 as an HPV type-independent cellular cor-
relate for increased HPV oncogene expression [23],
potential receptors for HPV (ITGA6, SDC) [24] and rep-
resentative genes of cancer-associated inflammation
(IL6, IL8, IL12A, IFNGR1, TNFA1P1) [25]. Additionally,
the effects of benzo-α-pyrene (BαP), one of the most im-
portant tobacco smoke carcinogens [26-29], as well as of
peptidoglycan (PEP) and lipopolysaccharide (LPS), both
known to induce IL6 and IL8 [30-33], were tested.
We found that the presence of HPV DNA in OSCC tis-
sues was rather low and appeared to be independent of in-
flammation or the presence of the potential HPV receptorITGA6 [34]. Virus uptake was only increased in vitro when
the cells were treated with benzo-α-pyrene, one of the
most abundant carcinogens in tobacco smoke.
Methods
Tissue collection
A total of 114 histopathologically-confirmed OSCC bi-
opsies together with corresponding adjacent normal
tissue samples were collected at both Groote Schuur
Hospital and Tygerberg Hospital, Cape Town, South
Africa, between 2008 and 2011. Patients were from differ-
ent ethnic groups with 66% being black (Xhosa-speaking),
32% of mixed ancestry, and 2% whites. Informed consent
was obtained from all participants, while ethical approval
for this study was obtained from the Ethics Committee of
the University of Cape Town. Samples were stored in
RNAlater solution (Qiagen) at −80°C until used for nucleic
acid extraction.
Cell culture
The immortalised human oesophageal epithelial cell line
EPC2-hTERT [35] was grown in Keratinocyte SFM
medium (Invitrogen) supplemented with 50 μg/ml bo-
vine pituitary extract (Invitrogen), 1 ng/ml human EGF
(Invitrogen), 100 U/ml penicillin and 100 μg/ml strepto-
mycin. WHCO1 (human OSCC cell line) [36], HaCaT
(spontaneously immortalized human keratinocyte cell
line and natural host for HPV [37], ATCC), C33A
(human HPV negative cervical cancer cell line, ATCC) and
293TT cells (virus packaging cell line established from
primary embryonal human kidney cells transformed with
modified human adenovirus) [38,39] were grown in
DMEM (Gibco Life Technologies) supplemented with
10% heat-inactivated fetal calf serum (Gibco Life Tech-
nologies), 100U/ml penicillin and 100 μg/ml strepto-
mycin. CHO-K1 (Chinese hamster epithelial-like cells,
ATCC) and pgsD-677 cells (heparin sulfate deficient
cells derived from CHO-K1, ATCC) were cultured in
Ham`s F-12 K medium (Gibco Life Technologies)
supplemented with 10% heat-inactivated fetal calf
serum, 100U/ml penicillin and 100 μg/ml streptomycin.
Nucleic acid extraction and PCR
Frozen biopsies were cut in half for parallel RNA and
genomic DNA extraction with the TRIzol reagent
(Invitrogen) and the QIAamp Mini Kit (Qiagen), respect-
ively. For PCR amplification of the HPV L1 gene, 100 ng
DNA was used in a nested PCR reaction containing the
degenerate consensus primers MY09/MY11 followed by
PCR with the primer set GP5+/GP6+ as described previ-
ously [14] using the FastStart Taq DNA polymerase
(Roche). The presence of EBV DNA was detected simi-
larly by targeting the virus capsid antigen p23 region by
nested PCR using the primer set p23-1/p23-2 followed
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tion of human β-actin was used as an internal control
(see Table 1 for all primer sequences and PCR product
sizes). The integrity of the PCR products was visualised
by agarose gel electrophoresis. The PCR products from
all HPV positive samples were subjected to DNA se-
quence analysis to determine the HPV type. For quantita-
tive RT-PCR, RNA extracted from the biopsies was
reverse transcribed using the ImProm-II™ Reverse Tran-
scription System (Promega). cDNA generated from 1 μg
of total RNA was used for quantitative PCR with the
KAPA SYBRWFAST qPCR Kit (Kapa Biosystems) on a
LightCyclerW480II System (Roche). Products were ampli-
fied with the primers listed in Table 1 under the following
conditions: 1 min 95°C, 1 min 55°C, 30s 72°C. Results were
analysed using the 2-ΔΔCT method [41], normalised toTable 1 Primers used in this study
Primer name Sequence (50-30) Length (bp)
pGL3 forw CGGGCGCGGTCGGTAAAGT 380
pGL3 rev AACAACGGCGGCGGGAAGT
p16 forw GCCACTCTCACCCGACCCGT 130
p16 rev TCAGCCAGGTCCACGGGCAGA
ITGA6 forw GCCAGCAAGGTGTAGCAGCTA 101
ITGA6 rev TTGCTCTACACGAACAATCCCTTT
SDC1 forw CCCCGTTTCTGGTGGTCT 175
SDC1 rev TGTCTGAAGGCTGAGTCCC
CD21 forw GCCGACACGACTACCAACC 150
CD21 rev AGCAAGTAACCAGATTCACAGC
IL8 forw GAGAGTGATTGAGAGTGGACCAC 111
IL8 rev CACAACCCTCTGCACCCAGTTT
IL6 SABiosciences (PPH00560B) 160
IL12A SABiosciences (PPH00544B) 82
IFNGR1 SABiosciences (PPH00871B) 112
TNFA1P1 SABiosciences (PPH01176A) 101
GAPDH forw GGCTCTCCAGAACATCATCC 192
GAPDH rev GCCTGCTTCACCACCTTC








β-actin forw ATCATGTTTGAGACCTTCAA 320
β-actin rev CATCTCTTGCTCGAAGTCCA
a M, A+C: R, A+G; W, A+T; Y, C+T;
b degenerate primers targeting the HPV late structural protein L1.GAPDH expression and represented as x-fold increase in
an individual tumour sample (T) compared to the corre-
sponding non-cancerous normal tissue (N) from the same
patient. Statistics were done to compare the significance of
gene expression in T versus N using the 2-tailed non-
parametric Mann–Whitney test. All primers were tested
for amplification of the correct products by conventional
PCR using appropriate tissue DNA.
HPV pseudovirion production, quantification and labelling
HPV16 and HPV18 pseudovirions encapsidating the lu-
ciferase reporter gene plasmid pGL3-control (Promega)
were generated in 293TT cells as previously described
[38,42]. The plasmid pXULL, coexpressing both codon-
optimized HPV16 L1 and L2, was generously provided
by Michelle Ozbun (University of New Mexico), while
the plasmid HPV18-L1/L2 was kindly provided by
Samuel K. Campos (University of Arizona). Purity and
L1/L2 protein content were determined by SDS-PAGE
and subsequent staining with the PierceW Silver Stain
Kit (Thermo Scientific). For PsVs labelling with a
fluorochrome that is only activated after cell entry [43],
20 μg of purified PsVs were mixed with 200 μM Oregon
GreenW488 carboxylic acid diacetate succinimidyl ester
(Molecular Probes) in a final volume of 500 μl HSB
(pH 7.5) and incubated for 24 h at room temperature in
the dark rotating. Unincorporated fluorochrome was re-
moved by washing and concentrating the labelled PsVs
using Amicon Ultra-4 (100,000 kDa MWCO) filter de-
vices (Millipore). To assess the amount of encapsidated
pGL3 plasmid DNA (viral genome equivalent, vge), all
purified pseudovirion preparations were subjected to
quantitative Light Cycler PCR using the primers pGL3
forw/pGL3 rev (Table 1).
HPV pseudovirion infection assays
Cells were seeded in 12-well plates at a density of 5×104
per well, and the following day cells were infected with a
vge of approximately 100 pseudovirion particles per cell.
For neutralisation assays, PsVs were incubated with the
neutralising antibodies H16.V5 and H18.J4, respectively
(generously provided by Neil D. Christensen, Pennsylvania
State University College of Medicine) for 1 h at 4°C before
adding to the cells. Where indicated, cells were stimulated
with either 200 ng/ml IFNγ (R&D systems), 100 ng/ml IL6
(R&D systems), 100 ng/ml IL8 (R&D systems), 50 ng/ml
IL12 (R&D systems), 5 μg/ml LPS (lipopolysaccharide)
from E. coli 0127: B8 (Sigma), 50 μg/ml PEP (peptido-
glycan) from S.aureus (Sigma) or 10 μM BαP (benzo-α-
pyrene) (Sigma) for 24 h before addition of the PsVs.
48 h after infection, cells were harvested and luciferase ac-
tivity was measured using the Luciferase Assay System kit
(Promega) with the Fluoroscan Ascent FL (Thermo Fisher
Scientific) according to the manufacturer’s instructions.
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rescently staining an independent set of samples with
5 μM CellTrace™ Oregon GreenW 488 (Molecular Probes)
in PBS for 5 min at room temperature. All experiments
were performed in duplicates, repeated at least three times
and calculated as means ± S.D. with the Student’s t test
used for determination of statistical significances.
To assess the uptake of PsVs that were labelled with
Oregon GreenW488 carboxylic acid diacetate succinimidyl
ester (Molecular Probes) as described above, cells were
seeded on coverslips in 6-well plates at a density of 2×105
per well, grown overnight and infected with a vge of ap-
proximately 500 pseudovirion particles per cell for 2 h.
Cells were washed, fixed with 4% paraformaldehyde and
mounted in mowialW4-88 reagent (Calbiochem) on glass
slides. Fluorescent cells were visualised using an Olympus
IX81S8F fluorescent microscope at 40x magnification.
Flow cytometry
Cells were prepared for FACS analysis as previously de-
scribed [44]. Rat anti-human ITGA6 (clone NKI-GoH3,
AbD Serotec) antibody together with R-Phycoerythrin-
conjugated donkey anti-rat IgG were used to detect
ITGA6 cell surface expression using a FACSCalibur
(Becton Dickinson) together with the software CellQuest.
Results
Viral infection and cellular gene expression in OSCC tissue
Based on the previous observation that 46% of OSCC
patients from the Eastern Cape (South Africa), a par-
ticularly high-incidence geographic area for OSCC,
contained integrated HPV DNA, predominantly HPV11
[14], we conducted a similar study in the Western Cape
of South Africa. A total of 114 biopsies collected from
histopathologically-confirmed OSCC patients were used
for the analysis of the expression profile of selected
genes and the presence of integrated HPV. Parallel de-
tection of Epstein-Barr Virus (EBV) DNA served as
technical control for the applied PCR-based detection
of viral DNA as EBV is known to be associated with
nasopharyngeal and gastric cancer [16,45] and possibly
oesophageal cancer [10,13]. We found that the potential
HPV receptor ITGA6 [24] and the EBV receptor CD21
EBV [46], that was included as control for a viral recep-
tor, were up-regulated in the tumour samples compared
to corresponding normal tissue, though CD21 did not
reach statistical significance (Figure 1A). Moreover, the
pro-inflammatory mediators IL6 and IL8 were signifi-
cantly overexpressed in the tumours, while IL12A was
significantly downregulated (Figure 1A). When OSCC gen-
omic DNA was analysed for viral gene integration by con-
ventional nested PCR, 9% of patients were found to be
positive for HPV while 26% were EBV positive (Figure 1B)
with the corresponding normal tissue being negative forHPV and EBV, respectively. The products derived from the
HPV-PCR were subjected to DNA sequence analysis which
revealed that the majority (8/10) of the HPV positive
OSCC biopsies contained the high-risk type HPV18 DNA.
Statistical analysis of the data shown in Figure 1A revealed
that there was no significant difference in the expression of
the cellular genes between tissues that tested positive or
negative for HPV DNA (Figure 1C), except for significantly
upregulated p16 in HPV positive OSCC tissues as would
be expected [23] (Figure 1C).
Infection of oesophageal epithelial and cancer cell lines
with HPV-PsVs
In order to elucidate whether inflammation influences
HPV infection, we established an in vitro infection assay
using HPV pseudovirions that were studied in the context
of selected cell lines that were exposed to inflammatory
stimuli. We prepared HPV pseudovirions that consisted of
the envelope proteins L1 and L2 of HPV18, the HPV type
that was mainly found in the HPV positive OSCC biopsies
(Figure 1B). Moreover, HPV16-specific PsVs were also pre-
pared so as to test a second oncogenic HPV genotype. Both
pseudovirion types encapsidated a luciferase reporter gene
plasmid so as to measure PsVs uptake into the cells. SDS-
PAGE and neutralisation assays were performed to assess
purity and functionality of the pseudovirion preparations.
As shown in Figure 2A and B, both HPV18-PsVs (luc) as
well as HPV16-PsVs (luc) displayed high purity with only
the L1 and L2 protein bands being detectable by SDS-
PAGE (Figure 2A). Both the L1 and the L2 protein are
about 500 amino acids in length. While the L1 protein has
an apparent size of 55 kDa on SDS-PAGE, the size of the
L2 protein has been observed to vary slightly between ge-
notypes; the reason for the aberrant mobility of the L2 pro-
tein is unknown [47]. When control HaCaT cells, were
infected with the HPV18-PsVs, we observed a complete
abolishment of infection when pre-incubated with the
HPV18-specific neutralising antibody H18.J4 while the
HPV16-specific neutralising antibody H16.V5 had no effect
(Figure 2B, left panel). Conversely, when HPV16-PsVs were
used we observed the opposite effect: the HPV16-specific
neutralising antibody H16.V5 inhibited infection while the
HPV18-specific neutralising antibody H18.J4 had no effect
(Figure 2B, right panel). These assays assured high purity
and quality of the respective HPV pseudovirion prepara-
tions that were used for all subsequent experiments. To
asses HPV pseudovirion infection in selected cell lines, we
chose the oesophageal epithelial cell line EPC2-hTERT and
the OSCC cell line WHCO1, while HaCaT normal skin
keratinocytes and the HPV negative cervical cancer cell
line C33A were used as controls of natural HPV infectable
cell lines. Infection with HPV18-PsVs (luc) revealed very
low infectivity of the two oesophageal cell lines when com-




Figure 1 Gene expression profile and infection with HPV and EBV in OSCC tissue. (A) A total of 114 OSCC biopsies (T) was tested for the
expression of the indicated genes by quantitative Light Cycler RT-PCR which is represented as x-fold increase compared to non-cancerous normal
(N) tissue from the same patient. GAPDH expression served as internal control and was used for normalisation of gene expression data. The
baseline at 20 indicates no difference in expression between N and T. Statistics were done to compare the significance of gene expression in
T versus N using the 2-tailed non-parametric Mann–Whitney test. Shown are the median values to account for outliers. *, p<0.05; **, p<0.01; ***,
p<0.001. (B) Representative agarose gel showing conventional PCR results for the detection of HPV and EBV sequences in the OSCC genomic
DNA. Separate amplification of ß-actin served as control for DNA integrity. The table summarizes the total number of OSCC samples that were
positive or negative for HPV and EBV, respectively. Percentages in brackets illustrate HPV and EBV infection, respectively. (C) Quantitative Light
Cycler RT-PCR data from (A) are depicted depending on HPV infection. Note that only upregulation of p16 in HPV positive OSCC samples reached
statistical significance compared to HPV negative samples.






Figure 2 Infection with HPV-PsVs in vitro. Luciferase reporter gene encapsidating HPV-PsVs composed of HPV18-L1/L2 or HPV16-L1/L2
envelope proteins, respectively, were prepared as described previously [38,42]. (A) Purity of the preparations was analyzed by SDS-PAGE followed
by silver staining. Note that the additional band at approximately 60 kDa in the HPV16-PsVs (luc) preparation is the silver-stained pGL3 plasmid
which is not present in the HPV16-PsVs preparation that does not encapsidate any DNA. (B) In order to test functionality of the preparations,
HaCaT cells were infected with HPV18-PsVs (luc) or HPV16-PsVs (luc) using a vge of 100 pseudovirion particles per cell. Luciferase activity was
measured 48 h post-infection. Neutralization experiments were performed for each pseudovirion preparation with antibodies against HPV16-L1/L2
(H16.V5) and HPV18-L1/L2 (H18.J4) envelope proteins as indicated. The experiments were done in duplicates, repeated three times and are
presented as % of luciferase activity to untreated controls. (C) The indicated cell lines were infected with equal amounts of HPV18-PsVs (luc) or
HPV16-PsVs (luc), respectively. Luciferase activity was measured 48 h post-infection. The experiments were performed in duplicates, repeated
three times and are presented as x-fold increase of luciferase activity to uninfected controls. (D) FACS analysis showing ITGA6 expression on the
surface of the indicated cell lines. In each panel, the dotted histogram corresponds to the negative control while the solid line shows the
histograms of cells stained with the ITGA6 antibody. (E) Cells were plated on coverslips and infected with equal amounts of HPV18-PsVs or
HPV16-PsVs, respectively, which were labeled with Oregon GreenW488 carboxylic acid diacetate succinimidyl ester, a fluorchrome that is only
activated after cell entry [43]. The cell line pgsD-677 which is defective in HPV uptake compared to the wildtype CHO-K1 counterpart [50] was
included as negative control. Pictures were taken on an Olympus IX81S8F fluorescent microscope at 40x magnification.
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panel). Similar results were obtained when these cells were
infected with HPV16-PsVs (luc) (Figure 2C, right panel).
Interestingly, C33A cells showed a much higher luciferase
activity when infected with HPV18-PsVs (luc) than with
HPV16-PsVs (luc).
The precise mechanism of HPV uptake is still unknown;
however, one of the cell surface molecules described as a
potential component of the cellular HPV receptor in
HaCaT cells is ITGA6 [34,48,49]. We found this receptor
to be significantly upregulated in the OSCC tissues com-
pared to corresponding normal tissues (Figure 1A) and in-
vestigated whether the differences in HPV pseudovirion
infectivity between the cell lines was correlated to the ex-
pression of ITGA6. Therefore, we analysed ITGA6 expres-
sion in EPC2-hTERT, WHCO1, HaCaT and C33A cells
and found that all tested cell lines substantially expressed
ITGA6 on their cell surfaces (Figure 2D). These data indi-
cate that the extent of ITGA6 expression could not be cor-
related to the observed differences in HPV infectivity
(Figure 2C).
To further elucidate whether the relatively low luciferase
activity detected in the two oesophageal cell lines was due
to impaired pseudovirion uptake, PsVs preparations were
labelled with Oregon GreenW488 carboxylic acid diacetate
succinimidyl ester, a fluorochrome that is only activated
after cell entry [43]. As shown in Figure 2E, all tested cell
lines displayed high intracellular fluorescence with the ex-
ception of pgsD-677 cells whose HPV-uptake is known to
be greatly reduced compared to their wildtype counter-
parts CHO-K1 [50]. It appears that EPC2-hTERT and
WHCO1 cells do take up the PsVs but do not express the
luciferase reporter gene. We confirmed the functionality of
the luciferase plasmid by transfection of pGL3 resulting in
comparable levels of luciferase activity in the tested cell
lines (data not shown).
Influence of inflammatory stimuli on HPV pseudovirion
uptake in vitro
The gene expression data derived from the OSCC biop-
sies that showed upregulation of IL6 and IL8 and
downregulation of IL12A (Figure 1A) were used to
mimic inflammation in oesophageal epithelial and can-
cer as well as control cell lines. Cells were stimulated
with IL6, IL8 and IL12 while the anti-viral cytokine IFNy
served as negative control. Additionally, the effects of
benzo-α-pyrene (BαP), peptidoglycan (PEP) and lipo-
polysaccharide (LPS) were tested. The appropriate dose
and incubation time for every tested drug or cytokine
was determined in preliminary experiments for each cell
line; shown is the highest concentration of each tested
substance that did not affect cell viability during 24 h in-
cubation. Treated cells were infected with HPV-PsVs and
analysed for luciferase activity. Except for BαP whichsignificantly and consistently enhanced HPV18-PsVs
(luc) reporter gene activity in the tested cell lines, none
of the other tested inflammatory stimulants facilitated
HPV pseudovirion uptake (Figure 3A). Similar results
were obtained for HPV16-PsVs (luc) (Figure 3B), though
the effect of BαP was not to the same extent as observed
for HPV18-PsVs (luc). Interestingly, the bacteria-derived
substances LPS and PEP reduced rather than increased
luciferase activity in the various cell lines. This result
was not due to cell death as the concentrations used
showed no effect of cytotoxicity (not shown). Moreover,
while IFNγ drastically reduced HPV pseudovirion in-
fectivity in EPC2-hTERT, WHCO1 and HaCaT cells,
C33A cells did not respond to the IFNγ treatment as
these cells are known to be defective in IFNγ signalling
[51] (Figure 3A and B).
Discussion
A number of human cancers have an infectious aetiology
that have been extensively studied in the past, the best
known being the association of HPV with cervical can-
cer [1]. However, recent studies suggest that viruses may
play a more significant role in several other malignancies
than the ones with a known viral association. HPV and
EBV for example, although widely debated, have been
implicated in oesophageal and nasopharyngeal cancers,
respectively [10-12,14-16]. While the consequences of
viral oncogenes and infection-related inflammation for
tumorigenesis have been extensively studied, the impact
of tumour-associated inflammation on viral infection is
much less understood.
In the present study we chose oesophageal squamous
cell carcinoma as an example as this type of cancer is
both associated with chronic irritation and inflammation
as well as viral infections. Although the role of HPV in
the carcinogenesis of OSCC is still debated, a previous
study from our laboratory found a high association of
HPV11 with OSCC from patients of the Eastern Cape,
South Africa [14]. Conducting a similar study with OSCC
samples from patients of the Western Cape in South
Africa, we here present evidence that underlying infec-
tion with HPV plays a minor role as only 9% of the
studied patient cohort was infected with HPV with
type 18 being the predominant one. Parallel analysis
for underlying infection with EBV that served as a
technical control for the applied PCR-based detection
of viral DNA revealed a slightly higher infection rate
of approximately 26%. While the low HPV infection
rate was rather unexpected, the number of OSCC pa-
tients that were infected with EBV correlates well with
the percentage of EBV DNA found in oral squamous
cell carcinoma from South African patients ranging
from 24% to 27% [52,53]. However, neither virus infec-
tion had any significant influence on the expression of
A
B
Figure 3 Influence of inflammatory stimuli on HPV pseudovirion uptake. The oesophageal epithelial cell line EPC2-hTERT, the OSCC cell line
WHCO1 as well as HaCaT and C33A control cells were stimulated with cytokines and irritants for 24 h as indicated, followed by infection with
HPV18-PsVs (luc) (A) or HPV16-PsVs (luc) (B), respectively. Cells were harvested 48 h post-infection and analyzed for luciferase activity. The
experiments were done in duplicates, repeated three times and are presented as x-fold increase in luciferase activity to untreated controls.
Statistics were done using 2-tailed unpaired t-test relative to untreated controls (*, p<0.05; **, p<0.01). Note that the luciferase activity of
untreated EPC2-hTERT cells was negligible (Figure 2C); therefore the measured values depicted only reach background activities.
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ceptors, although statistical analysis was rather lim-
ited due to the low number of HPV positive samples.
The observed upregulation of IL6 and IL8 and
downregulation of IL12A were therefore probably
due to tumour-specific immunological responses that
were independent of the presence of HPV. The high
variability observed between individual samples might
be explained by the complexity of the patient cohort
and the fact that no personal parameters (such as
age, sex, smoking and drinking status, ethnical and
social background, stage of tumour etc.) were taken
into account in the analysis. However, the large num-
ber of patients in the studied cohort allowed us toderive some general conclusion on the significance of
the expression profile of the selected genes.
From a technical point of view, detection of HPV se-
quences in the host genome is rather challenging [54,55].
While various PCR approaches targeting HPV-type specific
and HPV-type unspecific mRNA or inserted genomic
DNA were tested, including commercially available kits
(data not shown), only the widely described nested PCR
approach using the primer combination MY09/MY11
followed by GP5+/GP6+ targeting L1, the most conserved
protein among papillomaviruses [14,54-57], revealed
highest sensitivity and reproducibility. Indeed, only 60-80%
of our positive samples could be verified by a given alterna-
tive technique while only the combination of all data
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would confirm our (MY09/MY11//GP5+/GP6+)-nested
PCR-based results, therefore supporting our data as not
being false positives. The primer set MY09/MY11 that uses
degenerate primers to detect a wide range of HPV types
was not sufficient to pick up any HPV sequences in our pa-
tient cohort (data not shown), while a subsequent nested
PCR with the GP5+/GP6+ primer set that uses consensus
primers with a low annealing temperature to detect a simi-
lar range of HPV types resulted in HPV positive tissue
samples. However, this approach could still have
underestimated HPV prevalence as discussed before [55].
We conclude that both the infection rate as well as the
HPV copy number in our patient cohort were very low and
probably under the detection level of the particular assay
used. The low infection rate indicates that HPV is not a
major contributor to the carcinogenesis of OSCC in our
patient cohort. This is in agreement with a previous publi-
cation that suggests that low HPV copy numbers and infec-
tion rates are unlikely to play an essential role in OSCC
when compared to cervical cancer [18]. The low number
of HPV infected OSCC biopsies was not expected from
our previous study [14] but might be explained in part by
ethnical parameters and the different living circumstances
of the patients in the Eastern versus the Western Cape
[58,59]. The Eastern Cape of South Africa is a predomin-
antly poor and underdeveloped province consisting mainly
of tribal and informal urban areas with limited access to
health services. In contrast to the Western Cape, it has
particularly high rates of oesophageal cancer that are at-
tributed to risk factors such as poverty, underdevelop-
ment, poor nutrition and exposure to indoor smoke from
combustion of solid fuels [58,60,61]. Although still de-
bated as being the causative agent, it is assumed that
HPV infection is only associated with oesophageal can-
cers originating from high-incidence geographic areas
[11,17-20]. This might account for the significantly higher
HPV infection rate observed in our previous study [14];
however, infection with the non-oncogenic HPV type 11
might just be interpreted as an indirect measure of
poorer environmental conditions.
As HPV infection had no significant influence on in-
flammation in OSCC we next asked whether the op-
posite effect played a role, i.e. whether tumour-related
inflammation affected the uptake of virus particles.
Using HPV as a model, we set up an in vitro infection
assay and infected a panel of representative cell lines
with HPV-PsVs that were composed of the L1/L2 en-
velope proteins of HPV18 (as the majority of the HPV
positive OSCC biopsies were infected with HPV18) as
well as HPV16 (being the most common carcinogenic
HPV type worldwide [62,63] and have been reported
to be associated with oesophageal cancer [11,17,18]).
Surprisingly, we observed no or relatively low HPVpseudovirion infectivity of the immortalised normal
oesophageal epithelial cell line EPC2-hTERT and the
OSCC cell line WHCO1, respectively, compared to
HaCaT or C33A control cells. Although the measured re-
porter gene activities in EPC2-hTERT cells were negli-
gible, we found that these cells did take up the PsVs. We
therefore conclude that these cells might display a non-
infectious entry pathway with the virions possibly getting
stuck in endocytic vesicles. Unproductive internalization
with the hallmark of a stabilised capsid phenotype has
been described before [50,64] but was not further investi-
gated in this study as non-infectious uptake routes would
not lead to viral oncogene expression, therefore having
no relevance for the development of OSCC.
Interestingly, the observed differences in cell line in-
fectivity did not correlate with the presence of ITGA6.
Although questioned as a general HPV entry receptor
component [24,65], ITGA6 was found to play a role in
the uptake of HPV6b L1 pseudovirions into HaCaT
cells [34,48] as well as HPV16 L1-VLPs into various cell
lines [49]. Moreover, increased expression of ITGA6
was shown to be correlated with the development of
oesophageal cancer [66]; and increased aggressiveness,
drug resistance and poor prognosis has been correlated
with the presence of ITGA6 in leukemia [67]. However,
the observed upregulation of ITGA6 in the OSCC tis-
sues as well as its high expression on the surface of the
tested cell lines did not correlate with the extent of
HPV infectivity. Although we cannot exclude that
ITGA6 is involved in HPV uptake, our data indicate
that its presence and upregulation in the tumour sam-
ples do not play a rate limiting role in the establish-
ment of HPV infection. When the cell lines were
stimulated with various inflammatory agents or irritants
known to be associated with tumorigenesis of the
oesophagus [9], only benzo-α-pyrene facilitated HPV18
pseudovirion (and to a lesser extent HPV16) uptake.
BαP, one of the most important carcinogens in tobacco
smoke, has long been known to exert a wide range of
carcinogenic and pro-inflammatory effects [28,29]. In-
deed, both epidemiological evidence as well as in vitro
data exist to implicate interactions of HPV and cigarette
smoke carcinogens in the progression of cervical cancer
[26,27,68]. It was found that BαP increased the infectiv-
ity of the oncogenic HPV type 31b but did not directly
affect viral gene expression on a transcriptional level
[27]. The observed increase in luciferase activity upon
BαP treatment might therefore be a result of increased
pseudovirion uptake due to altered gene expression of
BαP-induced DNA adducts in the host cells [9]. It is
unlikely that the BαP-mediated HPV pseudovirion up-
take was due to an inflammatory response as none of
the tested substances associated with inflammation in-
creased HPV pseudovirion infectivity.
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Derived from the tested parameters, this study indicates
that neither tumour-associated inflammation nor viral
infection, particularly with HPV, seem to influence each
other in OSCC. Further, although highly expressed in
the tumour tissues, ITGA6 seems not to be involved in
HPV infection due to the low HPV infection rate.
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